VectorBuilder
@vectorbuilder.bsky.social
VectorBuilder is a global leader in gene delivery technologies.
Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
January 9, 2026 at 4:45 PM
Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
📣 Share Your Thoughts and Boost Your Research!
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
January 8, 2026 at 5:11 PM
📣 Share Your Thoughts and Boost Your Research!
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
Our Annual User Survey is now live, and we’d love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
VectorBuilder has partnered with UK-based Ikarovec Ltd in an exclusive collaboration to advance a promising one-time dual pathway gene therapy for intermediate age-related macular degeneration, a condition with no currently approved treatment options.
January 6, 2026 at 3:45 PM
VectorBuilder has partnered with UK-based Ikarovec Ltd in an exclusive collaboration to advance a promising one-time dual pathway gene therapy for intermediate age-related macular degeneration, a condition with no currently approved treatment options.
Lights are back on, lab benches are ready, & science is officially back in motion. We hope you had time to rest, reset, & maybe even let a few ideas incubate over the break. We’re ready to support your next experiments & discoveries. Here’s to fresh hypotheses & meaningful results in the year ahead!
January 5, 2026 at 6:49 PM
Lights are back on, lab benches are ready, & science is officially back in motion. We hope you had time to rest, reset, & maybe even let a few ideas incubate over the break. We’re ready to support your next experiments & discoveries. Here’s to fresh hypotheses & meaningful results in the year ahead!
In 2025, VectorBuilder went worldwide 🌍🧬
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
December 31, 2025 at 8:52 PM
In 2025, VectorBuilder went worldwide 🌍🧬
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward, wherever it happens.
In 2025, VectorBuilder’s Gene Delivery Seminar Series brought together expert insights, emerging technologies, and practical solutions from across the field. Thanks to our speakers and community for joining us. More to come in 2026!
December 30, 2025 at 5:42 PM
In 2025, VectorBuilder’s Gene Delivery Seminar Series brought together expert insights, emerging technologies, and practical solutions from across the field. Thanks to our speakers and community for joining us. More to come in 2026!
As the year winds down and experiments pause, we’re grateful for the scientists, collaborators, and innovators who made 2025 a great year. Thank you for building the future of science!
December 23, 2025 at 5:09 PM
As the year winds down and experiments pause, we’re grateful for the scientists, collaborators, and innovators who made 2025 a great year. Thank you for building the future of science!
Season’s Greetings from the VectorBuilder team! 🎄
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
December 22, 2025 at 7:05 PM
Season’s Greetings from the VectorBuilder team! 🎄
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
December 19, 2025 at 6:09 PM
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
December 18, 2025 at 7:49 PM
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
December 15, 2025 at 7:16 PM
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
December 10, 2025 at 7:59 PM
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
December 9, 2025 at 10:17 PM
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
December 5, 2025 at 7:22 PM
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
December 4, 2025 at 6:34 PM
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
December 2, 2025 at 5:27 PM
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
December 1, 2025 at 7:36 PM
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
The VectorBuilder team is headed to Hobart for the Australasian Neuroscience Society Annual Scientific Meeting! Catch our Territory Manager, Dr. Chee Ho H'ng, and our Associate Director, Dr. Thomas Leung!
November 27, 2025 at 6:08 PM
The VectorBuilder team is headed to Hobart for the Australasian Neuroscience Society Annual Scientific Meeting! Catch our Territory Manager, Dr. Chee Ho H'ng, and our Associate Director, Dr. Thomas Leung!
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
November 26, 2025 at 4:07 PM
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
MiniVec™ was created to reduce barriers and fuel new discoveries. We’re honored that Prof. Matthias Stephan and his team trust MiniVec™ to enhance efficiency, improve safety, and stay focused on the science that matters.
Now license fee–free through year-end!
Now license fee–free through year-end!
November 25, 2025 at 6:36 PM
MiniVec™ was created to reduce barriers and fuel new discoveries. We’re honored that Prof. Matthias Stephan and his team trust MiniVec™ to enhance efficiency, improve safety, and stay focused on the science that matters.
Now license fee–free through year-end!
Now license fee–free through year-end!
We’re excited to share that VectorBuilder received the 2025 Bioz Rapid Star Award for our vectors! This reflects the rapid rise in citations from researchers using our tools. Thank you for letting us be part of your discoveries!
November 24, 2025 at 5:09 PM
We’re excited to share that VectorBuilder received the 2025 Bioz Rapid Star Award for our vectors! This reflects the rapid rise in citations from researchers using our tools. Thank you for letting us be part of your discoveries!
Still unsure if MiniVec™ is right for your project?
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
November 21, 2025 at 5:40 PM
Still unsure if MiniVec™ is right for your project?
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
We were honored to take part in the Cold Spring Harbor Asia Conference (@cshasia.bsky.social) on Immunoreceptor Signaling and Therapeutic Applications, where our Founder and CSO, Dr. Bruce Lahn, contributed to the program.
November 18, 2025 at 5:20 PM
We were honored to take part in the Cold Spring Harbor Asia Conference (@cshasia.bsky.social) on Immunoreceptor Signaling and Therapeutic Applications, where our Founder and CSO, Dr. Bruce Lahn, contributed to the program.
Catch Dr. Morgan Dwyer at the 24th BioPharma Drug Discovery Nexus in Parsippany, New Jersey! Join her talk this Wednesday, Nov 19 at 8:40 AM on "Translating Success: The Importance of Early-Stage Vector Design for Cell and Gene Therapies."
November 17, 2025 at 9:05 PM
Catch Dr. Morgan Dwyer at the 24th BioPharma Drug Discovery Nexus in Parsippany, New Jersey! Join her talk this Wednesday, Nov 19 at 8:40 AM on "Translating Success: The Importance of Early-Stage Vector Design for Cell and Gene Therapies."
🧠 If you’re at #SfN25 and haven’t stopped by yet, come visit us at Booth #729 — the team is here and we still have plenty of colorful VectorBuilder swag and 2026 calendars to brighten your day.
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
November 17, 2025 at 6:36 PM
🧠 If you’re at #SfN25 and haven’t stopped by yet, come visit us at Booth #729 — the team is here and we still have plenty of colorful VectorBuilder swag and 2026 calendars to brighten your day.
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬